These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38561929)
61. Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in Hao Y; Lei Z; Shi N; Yu L; Ji W; Zhang X Front Endocrinol (Lausanne); 2021; 12():743517. PubMed ID: 35095753 [TBL] [Abstract][Full Text] [Related]
62. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Egbuna OI; Brown EM Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):129-48. PubMed ID: 18328986 [TBL] [Abstract][Full Text] [Related]
63. A cell function study on calcium regulation of a novel calcium-sensing receptor mutation (p.Tyr825Phe). Moon JE; Yang HY; Wee G; ParK SH; Ko CW Ann Pediatr Endocrinol Metab; 2021 Mar; 26(1):24-30. PubMed ID: 32871647 [TBL] [Abstract][Full Text] [Related]
64. Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss-of-Function Gα Gorvin CM; Hannan FM; Cranston T; Valta H; Makitie O; Schalin-Jantti C; Thakker RV J Bone Miner Res; 2018 Jan; 33(1):32-41. PubMed ID: 28833550 [TBL] [Abstract][Full Text] [Related]
65. Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification. Hough TA; Bogani D; Cheeseman MT; Favor J; Nesbit MA; Thakker RV; Lyon MF Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13566-71. PubMed ID: 15347804 [TBL] [Abstract][Full Text] [Related]
67. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. Vargas-Poussou R; Huang C; Hulin P; Houillier P; Jeunemaître X; Paillard M; Planelles G; Déchaux M; Miller RT; Antignac C J Am Soc Nephrol; 2002 Sep; 13(9):2259-66. PubMed ID: 12191970 [TBL] [Abstract][Full Text] [Related]
68. Nanobodies as negative allosteric modulators for human calcium sensing receptor. Cui Q; Wang L; Wang H; Chen X; Han L; Geng T; Kou Y; Zhang W; Dai M; Qiao H; Sun Z; Li L; Lan Z; Xu H; Xu J; Dai Y; Geng Y Biochem Biophys Res Commun; 2024 Feb; 695():149401. PubMed ID: 38154264 [TBL] [Abstract][Full Text] [Related]
69. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia. Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291 [TBL] [Abstract][Full Text] [Related]
70. Insights into calcium-sensing receptor trafficking and biased signalling by studies of calcium homeostasis. Gorvin CM J Mol Endocrinol; 2018 Jul; 61(1):R1-R12. PubMed ID: 29599414 [TBL] [Abstract][Full Text] [Related]
71. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia. Lietman SA; Tenenbaum-Rakover Y; Jap TS; Yi-Chi W; De-Ming Y; Ding C; Kussiny N; Levine MA J Clin Endocrinol Metab; 2009 Nov; 94(11):4372-9. PubMed ID: 19789209 [TBL] [Abstract][Full Text] [Related]
72. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia. Hirai H; Nakajima S; Miyauchi A; Nishimura K; Shimizu N; Shima M; Michigami T; Ozono K; Okada S J Hum Genet; 2001; 46(1):41-4. PubMed ID: 11289719 [TBL] [Abstract][Full Text] [Related]
73. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor. Grant MP; Stepanchick A; Breitwieser GE Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345 [TBL] [Abstract][Full Text] [Related]
74. The three common polymorphisms p.A986S, p.R990G and p.Q1011E in the calcium sensing receptor (CASR) are not associated with chronic pancreatitis. Ewers M; Canaff L; Weh AE; Masson E; Eiseler K; Chen JM; Rebours V; Bugert P; Michl P; Rosendahl J; Férec C; Goltzman D; Witt H Pancreatology; 2021 Oct; 21(7):1299-1304. PubMed ID: 34446336 [TBL] [Abstract][Full Text] [Related]
75. Loss-of-function and gain-of-function mutations of calcium-sensing receptor: functional analysis and the effect of allosteric modulators NPS R-568 and NPS 2143. Nakamura A; Hotsubo T; Kobayashi K; Mochizuki H; Ishizu K; Tajima T J Clin Endocrinol Metab; 2013 Oct; 98(10):E1692-701. PubMed ID: 23966241 [TBL] [Abstract][Full Text] [Related]
76. GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts. Mayr B; Schnabel D; Dörr HG; Schöfl C Eur J Endocrinol; 2016 May; 174(5):R189-208. PubMed ID: 26646938 [TBL] [Abstract][Full Text] [Related]
77. Identification of p.Arg205Cys in CASR in an autosomal dominant hypocalcaemia type 1 pedigree: A case report. Ji Y; Kang C; Chen J; Zhang L Medicine (Baltimore); 2021 Jun; 100(25):e26443. PubMed ID: 34160437 [TBL] [Abstract][Full Text] [Related]